World's Best Scientists 2026 revealed!
Tatsuya Atsumi

Tatsuya Atsumi

D-Index & Metrics

Immunology

D-Index
76
Citations
29539
World Ranking
1865
National Ranking
71

Tatsuya Atsumi publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Tatsuya Atsumi sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 713 publications — 96th percentile

96% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Tatsuya Atsumi D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Tatsuya Atsumi sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 76 D-Index — 62nd percentile

62% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Tatsuya Atsumi is affiliated with Hokkaido University in Japan and has contributed extensively to the field of medicine with a particular focus on rheumatology, endocrinology, diabetes, metabolism, genetics, surgery, and pulmonary and respiratory medicine. Their research spans multiple subfields, reflecting a broad expertise within clinical and biomedical sciences.

Their work encompasses a range of topics including systemic lupus erythematosus research, rheumatoid arthritis research and therapies, diabetes treatment and management, pancreatic function and diabetes, vasculitis and related conditions, metabolism, diabetes, and cancer, as well as systemic sclerosis and related diseases.

Among the recent publications associated with or relevant to Atsumi's research environment, the following notable papers are highlighted:

  • Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial, 2020, The Lancet Respiratory Medicine
  • The 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria, 2023, Arthritis & Rheumatology
  • 2023 ACR/EULAR antiphospholipid syndrome classification criteria, 2023, Annals of the Rheumatic Diseases
  • Effect of Reduced-Dose vs High-Dose Glucocorticoids Added to Rituximab on Remission Induction in ANCA-Associated Vasculitis, 2021, JAMA
  • Filgotinib in combination with methotrexate or as monotherapy versus methotrexate monotherapy in patients with active rheumatoid arthritis and limited or no prior exposure to methotrexate: the phase 3, randomised controlled FINCH 3 trial, 2021, Annals of the Rheumatic Diseases

Atsumi has collaborated frequently with scholars such as Akinobu Nakamura, Hiraku Kameda, Hiroshi Nomoto, Kyu Yong Cho, and Hideaki Miyoshi, with these coauthors appearing respectively 87, 83, 78, 65, and 65 times in shared publications. This indicates a robust research network within the medical research community in Japan and internationally.

Publication venues where Atsumi's work or closely related work appears commonly include Modern Rheumatology, Annals of the Rheumatic Diseases, Diabetes, Journal of the Endocrine Society, and Lara D. Veeken, with counts of 32, 28, 22, 20, and 14 publications respectively. This reflects engagement with high-impact journals focusing on rheumatology, diabetes, and endocrinology.

The main research field for Atsumi is medicine, with 724 publications, underscoring a significant contribution to health sciences research. Within this broad field, particular emphasis on rheumatology with 139 publications highlights a specialized focus area.

Best Publications

  • International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS).

    S. Miyakis;M. D. Lockshin;T. Atsumi;D. W. Branch

  • ANTIPHOSPHOLIPID ANTIBODIES AFFECT TROPHOBLAST GONADOTROPIN SECRETION AND INVASIVENESS BY BINDING DIRECTLY AND THROUGH ADHERED β2-GLYCOPROTEIN I

    N Di Simone;P L Meroni;N Del Papa;E Raschi

  • Ixekizumab, an interleukin-17A antagonist in the treatment of ankylosing spondylitis or radiographic axial spondyloarthritis in patients previously untreated with biological disease-modifying anti-rheumatic drugs (COAST-V): 16 week results of a phase 3 randomised, double-blind, active-controlled and placebo-controlled trial

    Désirée van der Heijde;James Cheng-Chung Wei;Maxime Dougados;Philip Mease

  • Clinical features of haemophagocytic syndrome in patients with systemic autoimmune diseases: analysis of 30 cases

    S Fukaya;S Yasuda;T Hashimoto;K Oku

  • Association of autoantibodies against the phosphatidylserine-prothrombin complex with manifestations of the antiphospholipid syndrome and with the presence of lupus anticoagulant.

    Tatsuya Atsumi;Masahiro Ieko;Maria L. Bertolaccini;Kenji Ichikawa

  • The role of the tissue factor pathway in the hypercoagulable state in patients with the antiphospholipid syndrome

    Olga Amengual;Tatsuya Atsumi;Munther A. Khamashta;Graham R. V. Hughes

  • Efficacy of the antiphospholipid score for the diagnosis of antiphospholipid syndrome and its predictive value for thrombotic events

    Kotaro Otomo;Tatsuya Atsumi;Olga Amengual;Yuichiro Fujieda

  • Enhanced Formation and Disordered Regulation of NETs in Myeloperoxidase-ANCA–Associated Microscopic Polyangiitis

    Daigo Nakazawa;Haruki Shida;Utano Tomaru;Masaharu Yoshida

  • Outcome of patients with anticardiolipin antibodies: a 10 year follow-up of 52 patients:

    N. M. Shah;M. A. Khamashta;T. Atsumi;G. R. V. Hughes

  • 14th International Congress on Antiphospholipid Antibodies Task Force. Report on antiphospholipid syndrome laboratory diagnostics and trends

    Maria Laura Bertolaccini;Olga Amengual;Laura Andreoli;Tatsuya Atsumi

  • Circulating oxidized LDL forms complexes with β2-glycoprotein I implication as an atherogenic autoantigen

    Kazuko Kobayashi;Makoto Kishi;Tatsuya Atsumi;Maria L. Bertolaccini

  • Complement activation in patients with primary antiphospholipid syndrome

    Kenji Oku;Tatsuya Atsumi;Miyuki Bohgaki;Olga Amengual

  • Testing for Antiphospholipid antibodies with Solid Phase Assays: guidance from the SSC of the ISTH

    Katrien Devreese;SS Pierangeli;B De Laat;A Tripodi

  • Specificity of ELISA for antibody to beta 2-glycoprotein I in patients with antiphospholipid syndrome.

    O. Amengual;T. Atsumi;M. A. Khamashta;T. Koike

  • The responses of macrophages in interaction with neutrophils that undergo NETosis.

    Daigo Nakazawa;Haruki Shida;Yoshihiro Kusunoki;Arina Miyoshi

  • The Phenotype of Infiltrating Macrophages Influences Arteriosclerotic Plaque Vulnerability in the Carotid Artery

    Kyu Yong Cho;Hideaki Miyoshi;Satoshi Kuroda;Hiroshi Yasuda

  • Incidence and Risk Factors for Serious Infection in Patients with Rheumatoid Arthritis Treated with Tumor Necrosis Factor Inhibitors: A Report from the Registry of Japanese Rheumatoid Arthritis Patients for Longterm Safety

    Yukiko Komano;Michi Tanaka;Toshihiro Nanki;Ryuji Koike

  • A specific ligand for β2-glycoprotein I mediates autoantibody-dependent uptake of oxidized low density lipoprotein by macrophages

    Kazuko Kobayashi;Eiji Matsuura;Qingping Liu;Jun Ichi Furukawa

  • Clinical characteristics of cytomegalovirus infection in rheumatic diseases: multicentre survey in a large patient population

    Y. Takizawa;S. Inokuma;Y. Tanaka;K. Saito

  • The efficacy of tacrolimus in patients with interstitial lung diseases complicated with polymyositis or dermatomyositis

    Takashi Kurita;Shinsuke Yasuda;Koji Oba;Toshio Odani

  • The p38 mitogen-activated protein kinase (MAPK) pathway mediates induction of the tissue factor gene in monocytes stimulated with human monoclonal anti-β2Glycoprotein I antibodies

    Miyuki Bohgaki;Tatsuya Atsumi;Yumi Yamashita;Shinsuke Yasuda

Frequent Co-Authors

Takao Koike
Takao Koike Hokkaido University
Munther A. Khamashta
Munther A. Khamashta King's College London
Yoshiya Tanaka
Yoshiya Tanaka University of Occupational and Environmental Health Japan
Tsutomu Takeuchi
Tsutomu Takeuchi Keio University
Yasuo Terauchi
Yasuo Terauchi Yokohama City University
Eiji Matsuura
Eiji Matsuura Okayama University
Nobuyuki Miyasaka
Nobuyuki Miyasaka Tokyo Medical and Dental University
Yoshinari Takasaki
Yoshinari Takasaki Juntendo University
Graham R. V. Hughes
Graham R. V. Hughes London Bridge Hospital

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in Immunology, pursuing related healthcare degrees can open diverse career avenues. Many professionals transition within nursing specialties, such as moving from Family Nurse Practitioner (FNP) roles to more specialized fields. Understanding how to fnp to acute care np can be crucial for those aiming to work in critical care settings with immunological patients.

Accelerated programs offer a fast track to nursing roles. For example, nurses can explore accelerated fnp programs to advance their practice swiftly. Similarly, individuals without a nursing background can enter the field through well-designed online courses, making the best online rn programs for non nurses an excellent starting point.

For those seeking expedited nursing education, identifying the easiest absn program to get into can help in earning a Bachelor of Science in Nursing efficiently. Such programs often provide the flexibility and support needed for busy students.

Overall, these pathways complement Immunology studies by preparing graduates for impactful healthcare roles, enhancing their ability to apply immunological knowledge in clinical practice.

Best Scientists Citing Tatsuya Atsumi

Trending Scientists

Recently Published Articles